Patents by Inventor Robert E. Atkinson

Robert E. Atkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12251128
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.
    Type: Grant
    Filed: February 8, 2023
    Date of Patent: March 18, 2025
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson, Matthew J. Olson
  • Publication number: 20250057564
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Application
    Filed: November 5, 2024
    Publication date: February 20, 2025
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON
  • Patent number: 12214144
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a lumen extending therein; inserting the device into the vascular lumen; positioning the distal portion in the vascular wall; and directing the distal portion within the vascular wall.
    Type: Grant
    Filed: September 20, 2023
    Date of Patent: February 4, 2025
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 12161358
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: December 10, 2024
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Publication number: 20240358975
    Abstract: Introducer sheath systems including a pressure regulator operably coupled to a hemostatic valve, wherein the pressure regulator includes a chamber filled with a gas that is fluidly isolated from the hemostatic valve. The introducer sheath systems may include a tubular sheath, a hub assembly, and a dilator disposed therein connected to a proximal end of the sheath; the hub assembly including a housing and a hemostatic valve disposed therein; a pressure regulator connected to the hub and in fluid communication with the hemostatic valve; and a sealed chamber defined by the pressure regulator, the chamber having an interior, wherein the interior of the chamber is filled with a gas that is fluidly isolated from the hemostatic valve.
    Type: Application
    Filed: April 24, 2024
    Publication date: October 31, 2024
    Applicant: Cultiv8 1, LLC
    Inventors: Kyle P. TAYLOR, Michael BRENZEL, David Matthew COSTELLO, Robert E. ATKINSON
  • Publication number: 20240058029
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a side port, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall, directing the distal portion within the vascular wall such that the distal portion moves at least partially laterally, and directing the side port towards the vascular lumen.
    Type: Application
    Filed: October 17, 2023
    Publication date: February 22, 2024
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON
  • Publication number: 20240001085
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a lumen extending therein; inserting the device into the vascular lumen; positioning the distal portion in the vascular wall; and directing the distal portion within the vascular wall.
    Type: Application
    Filed: September 20, 2023
    Publication date: January 4, 2024
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON
  • Publication number: 20230414233
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Application
    Filed: September 7, 2023
    Publication date: December 28, 2023
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: CHAD J. KUGLER, MATTHEW J. OLSON, ROBERT E. ATKINSON
  • Patent number: 11826070
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a side port, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall, directing the distal portion within the vascular wall such that the distal portion moves at least partially laterally, and directing the side port towards the vascular lumen.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: November 28, 2023
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 11793978
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a lumen extending therein; inserting the device into the vascular lumen; positioning the distal portion in the vascular wall; and directing the distal portion within the vascular wall.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: October 24, 2023
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 11779361
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: October 10, 2023
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Chad J. Kugler, Matthew J. Olson, Robert E. Atkinson
  • Publication number: 20230190331
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.
    Type: Application
    Filed: February 8, 2023
    Publication date: June 22, 2023
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON, MATTHEW J. OLSON
  • Publication number: 20230191124
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.
    Type: Application
    Filed: December 16, 2022
    Publication date: June 22, 2023
    Applicant: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
  • Patent number: 11607245
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: March 21, 2023
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson, Matthew J. Olson
  • Patent number: 11529514
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: December 20, 2022
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
  • Patent number: 11517746
    Abstract: A stimulation system for delivery of a stimulation signal to a hypoglossal nerve of a patient to treat obstructive sleep apnea. The stimulation system includes an implantable receiver coil configured to be implanted under a mandible of the patient; a nerve electrode coupled to the implantable receiver coil, the nerve electrode configured to deliver the stimulation signal to the hypoglossal nerve of the patient; an external pulse generator configured to generate the stimulation signal; and an external transmitter coil configured to wirelessly transmit the stimulation signal from the external pulse generator to the implantable receiver coil, the external transmitter coil being carried by an adhesive patch configured to be placed on the skin adjacent the implantable receiver coil under the mandible of the patient.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: December 6, 2022
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20220346943
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.
    Type: Application
    Filed: July 1, 2022
    Publication date: November 3, 2022
    Applicants: Alcon Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul MCLEAN, Robert E. ATKINSON
  • Patent number: 11406490
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: August 9, 2022
    Assignees: Alcon Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. Kahook, Naresh Mandava, Glenn Sussman, Paul McLean, Robert E. Atkinson
  • Patent number: 11400287
    Abstract: An implantable neurostimulation system comprises a stimulation delivery lead and a neurostimulator. The stimulation delivery lead is coupled to an electrode. The neurostimulator is adapted to deliver a neurostimulation signal to the subject and comprises a microprocessor. The microprocessor is programmed to identify a stimulation operating window for the therapy including a first threshold and a second threshold. The second threshold comprises an awake level and an asleep level. Identifying the stimulation operating window comprises titrating a stimulation setting of the neurostimulator while the subject is awake until the first threshold and the awake level of the second threshold are identified. Identifying the stimulation operating window further comprises subsequently repeating the step of titrating the stimulation setting of the neurostimulator while the subject is asleep until the asleep level of the second threshold is identified.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: August 2, 2022
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson, Peter R. Eastwood, David R. Hillman
  • Publication number: 20220096803
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a lumen extending therein; inserting the device into the vascular lumen; positioning the distal portion in the vascular wall; and directing the distal portion within the vascular wall.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Applicant: BRIDGEPOINT MEDICAL, INC.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON